- ►diabetesjournals.org DG Marrero, J Crean, B Zhang, T Kellmeyer, … - Diabetes care, 2007 - Am Diabetes Assoc RESULTS—Pramlintide-treated patients reported greater treatment satisfaction
in most questionnaire responses. Treatment satisfaction was similar for
pramlintide-treated patients regardless of intensive insulin regimens (MDI ... Cited by 13 - Related articles - BL Direct - All 6 versions
- ►adisonline.com [PDF] BCT Field, AM Wren, D Cooke, SR Bloom - Drugs, 2008 - ingentaconnect.com Food intake and bodyweight are tightly regulated by the brainstem, hypothala-
Abstract mus and reward circuits. These centres integrate diverse cognitive
inputs with humoral and neuronal signals of nutritional status. Our ... Cited by 8 - Related articles - BL Direct - All 5 versions
J Pullman, T Darsow, JP Frias - Vascular Health and Risk Management, 2006 - pubmedcentral.nih.gov In patients with diabetes, dysregulation of multiple glucoregulatory hormones
results in chronic hyperglycemia and an array of associated microvascular and
macrovascular complications. Optimization of glycemic control, both overall ... Cited by 7 - Related articles - BL Direct - All 7 versions
BJ Hoogwerf, KB Doshi, D Diab - Vascular Health and Risk Management, 2008 - pubmedcentral.nih.gov Pramlintide is a synthetic version of the naturally occurring pancreatic peptide
called amylin. Amylin and pramlintide have similar effects on lowering
postprandial glucose, lowering postprandial glucagon and delaying gastric ... Cited by 8 - Related articles - BL Direct - All 7 versions
RR Rubin, M Peyrot - Current Medical Research and Opinion®, 2007 - informahealthcare.com Objective: This study was designed to assess treatment satisfaction in patients
using pramlintide who had not previously achieved glycemic targets with insulin
therapy alone. Assessment included the association between treatment ... Cited by 5 - Related articles - BL Direct - All 4 versions
- ►insulinjournal.com [PDF] JM Perkins, SN Davis - Insulin, 2007 - Elsevier Data show that controlling prandial hyperglycemia reduces the risk of
cardiovascular disease (CVD) andmicrovascular complications, lowers glycosylated
hemoglobin levels, causes less oxidative stress, and leads to a more ... Cited by 4 - Related articles - All 2 versions
AH Stonehouse, DG Maggs - Current Drug Therapy, 2007 - ingentaconnect.com Abstract: Type 2 diabetes results from progressive -cell dysfunction and insulin
resistance, leading to progressive wors- ening of glycemic control, and
increased risk of microvascular and macrovascular complications. ... Cited by 5 - Related articles - BL Direct
DF Kruger, SL Aronoff, SV Edelman - The Diabetes Educator, 2007 - tde.sagepub.com From the Division of Endocrinology and Metabolism, Henry Ford Health System,
Detroit, Michigan (Ms Kruger); the Research Institute of Dallas, University of
Texas Southwestern Medical School at Dallas, and Endocrine Associates of ... Cited by 3 - Related articles - BL Direct - All 4 versions
